$AWHL Income Statement | Understand Stock

$AWHL

$0.30 +$0.00 (0.0%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue:
Product
Genetics
Total revenue
Product
Genetics
Total revenue
Cost of revenue
Product
Genetics
Total cost of revenue

Gross profit
Operating expenses:
Research and development
Sales and marketing
General and administrative
Total operating expenses
Loss from operations
Other (expense) income, net:
Change in fair value of warrant liabilities
Change in fair value of convertible notes
Loss upon issuance of convertible notes carried at fair value
Interest expense, net
Forgiveness of DECD loan
Other income (expense), net
Total other (expense) income, net
Net loss
Net loss per share - basic and diluted
Weighted average common shares used to compute basic and diluted net loss per common share
Net loss per share - basic (in dollars per share)
Net loss per share - diluted (in dollars per share)
Weighted average common shares used to compute basic net loss per common share (in shares)
Weighted average common shares used to compute diluted net loss per common share (in shares)

Comments